LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.…
Lifevantage Corp (LFVN) (Q1 2027) Earnings Call Highlights: Revenue Slides 22% as Strategic ...
LifeVantage (NASDAQ: LFVN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 209 employees.
The shares were at 4.150 USD on 20 November 2026, down 43.0% over 52 weeks. Its 52-week range is 3.900 USD to 11.71 USD: the price is 64.6% below the high and 6.4% above the low.
At a market capitalisation of 52.63M USD, it trades at 19.8 times trailing earnings and 27.7 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, a discount of 20% for LFVN. It pays a dividend yielding 4.06% (it pays out 90% of its earnings), against a median of 3.67% among the dividend payers in that peer group.
LifeVantage reports return on equity of 15.1%, an operating margin of 2.5% and revenue down 22.0% year over year.
It holds more cash than debt, a net cash position of 4.32M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 6.500 USD is 56.6% above the current price. The next earnings report is expected on 4 February 2027.